ID   LIPT_HUMAN              Reviewed;         373 AA.
AC   Q9Y234; Q4ZFZ1;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-MAR-2017, entry version 131.
DE   RecName: Full=Lipoyltransferase 1, mitochondrial;
DE            EC=2.3.1.-;
DE   AltName: Full=Lipoate biosynthesis protein;
DE   AltName: Full=Lipoate-protein ligase;
DE   AltName: Full=Lipoyl ligase;
DE   Flags: Precursor;
GN   Name=LIPT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10103005; DOI=10.1046/j.1432-1327.1999.00204.x;
RA   Fujiwara K., Suzuki M., Okumachi Y., Okamura-Ikeda K., Fujiwara T.,
RA   Takahashi E., Motokawa Y.;
RT   "Molecular cloning, structural characterization and chromosomal
RT   localization of human lipoyltransferase gene.";
RL   Eur. J. Biochem. 260:761-767(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow, Lung, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN LIPT1D, AND VARIANT LIPT1D ALA-179.
RX   PubMed=24341803; DOI=10.1186/1750-1172-8-192;
RA   Soreze Y., Boutron A., Habarou F., Barnerias C., Nonnenmacher L.,
RA   Delpech H., Mamoune A., Chretien D., Hubert L., Bole-Feysot C.,
RA   Nitschke P., Correia I., Sardet C., Boddaert N., Hamel Y.,
RA   Delahodde A., Ottolenghi C., de Lonlay P.;
RT   "Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease
RT   with secondary deficiency for pyruvate and alpha-ketoglutarate
RT   dehydrogenase.";
RL   Orphanet J. Rare Dis. 8:192-192(2013).
RN   [6]
RP   VARIANTS LIPT1D PHE-71 AND GLY-98.
RX   PubMed=24256811; DOI=10.1093/hmg/ddt585;
RA   Tort F., Ferrer-Cortes X., Thio M., Navarro-Sastre A., Matalonga L.,
RA   Quintana E., Bujan N., Arias A., Garcia-Villoria J., Acquaviva C.,
RA   Vianey-Saban C., Artuch R., Garcia-Cazorla A., Briones P., Ribes A.;
RT   "Mutations in the lipoyltransferase LIPT1 gene cause a fatal disease
RT   associated with a specific lipoylation defect of the 2-ketoacid
RT   dehydrogenase complexes.";
RL   Hum. Mol. Genet. 23:1907-1915(2014).
CC   -!- FUNCTION: Catalyzes the transfer of the lipoyl group from lipoyl-
CC       AMP to the specific lysine residue of lipoyl domains of lipoate-
CC       dependent enzymes. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Lipoyl-AMP + protein = protein N(6)-
CC       (lipoyl)lysine + AMP.
CC   -!- PATHWAY: Protein modification; protein lipoylation via exogenous
CC       pathway; protein N(6)-(lipoyl)lysine from lipoate: step 2/2.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle and heart,
CC       moderately in kidney and pancreas, and detected at lower levels in
CC       liver, brain, placenta and lung. {ECO:0000269|PubMed:10103005}.
CC   -!- DISEASE: Lipoyltransferase 1 deficiency (LIPT1D) [MIM:616299]: A
CC       disorder due to a defect in lipoic acid metabolism, resulting in
CC       severe lactic acidosis and metabolic decompensation. Variable
CC       clinical manifestations include delayed psychomotor development,
CC       severe hypotonia, dystonia, loss of head control, coma,
CC       bradycardia, and pulmonary hypertension.
CC       {ECO:0000269|PubMed:24256811, ECO:0000269|PubMed:24341803}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the LplA family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB017566; BAA76367.1; -; mRNA.
DR   EMBL; AB017567; BAA76368.1; -; Genomic_DNA.
DR   EMBL; AC092587; AAX88927.1; -; Genomic_DNA.
DR   EMBL; CH471127; EAX01877.1; -; Genomic_DNA.
DR   EMBL; BC007001; AAH07001.1; -; mRNA.
DR   EMBL; BC009772; AAH09772.1; -; mRNA.
DR   EMBL; BC070145; AAH70145.1; -; mRNA.
DR   CCDS; CCDS2039.1; -.
DR   RefSeq; NP_001191759.1; NM_001204830.1.
DR   RefSeq; NP_057013.1; NM_015929.3.
DR   RefSeq; NP_660198.1; NM_145197.2.
DR   RefSeq; NP_660199.1; NM_145198.2.
DR   RefSeq; NP_660200.1; NM_145199.2.
DR   UniGene; Hs.719172; -.
DR   UniGene; Hs.739177; -.
DR   ProteinModelPortal; Q9Y234; -.
DR   SMR; Q9Y234; -.
DR   BioGrid; 119630; 7.
DR   IntAct; Q9Y234; 1.
DR   MINT; MINT-1385603; -.
DR   STRING; 9606.ENSP00000342071; -.
DR   DrugBank; DB00166; Lipoic Acid.
DR   iPTMnet; Q9Y234; -.
DR   PhosphoSitePlus; Q9Y234; -.
DR   BioMuta; LIPT1; -.
DR   DMDM; 25167326; -.
DR   EPD; Q9Y234; -.
DR   MaxQB; Q9Y234; -.
DR   PaxDb; Q9Y234; -.
DR   PeptideAtlas; Q9Y234; -.
DR   PRIDE; Q9Y234; -.
DR   DNASU; 51601; -.
DR   Ensembl; ENST00000393471; ENSP00000377114; ENSG00000144182.
DR   Ensembl; ENST00000393473; ENSP00000377115; ENSG00000144182.
DR   GeneID; 51601; -.
DR   KEGG; hsa:51601; -.
DR   UCSC; uc002szo.5; human.
DR   CTD; 51601; -.
DR   DisGeNET; 51601; -.
DR   GeneCards; LIPT1; -.
DR   HGNC; HGNC:29569; LIPT1.
DR   HPA; HPA034802; -.
DR   MalaCards; LIPT1; -.
DR   MIM; 610284; gene.
DR   MIM; 616299; phenotype.
DR   neXtProt; NX_Q9Y234; -.
DR   OpenTargets; ENSG00000144182; -.
DR   Orphanet; 255241; Leigh syndrome with leukodystrophy.
DR   Orphanet; 401862; Lipoyl transferase 1 deficiency.
DR   PharmGKB; PA134940073; -.
DR   eggNOG; KOG3159; Eukaryota.
DR   eggNOG; COG0095; LUCA.
DR   GeneTree; ENSGT00390000008846; -.
DR   HOGENOM; HOG000260595; -.
DR   HOVERGEN; HBG028203; -.
DR   InParanoid; Q9Y234; -.
DR   KO; K10105; -.
DR   OMA; WRNAETV; -.
DR   OrthoDB; EOG091G09SS; -.
DR   PhylomeDB; Q9Y234; -.
DR   TreeFam; TF314085; -.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   UniPathway; UPA00537; UER00595.
DR   GenomeRNAi; 51601; -.
DR   PRO; PR:Q9Y234; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000144182; -.
DR   ExpressionAtlas; Q9Y234; baseline and differential.
DR   Genevisible; Q9Y234; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0016979; F:lipoate-protein ligase activity; IBA:GO_Central.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; TAS:Reactome.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0009249; P:protein lipoylation; IBA:GO_Central.
DR   InterPro; IPR004143; BPL_LPL_catalytic.
DR   InterPro; IPR004562; LipoylTrfase_LipoateP_Ligase.
DR   PANTHER; PTHR12561; PTHR12561; 1.
DR   TIGRFAMs; TIGR00545; lipoyltrans; 1.
DR   PROSITE; PS51733; BPL_LPL_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Disease mutation; Mitochondrion;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     25       Mitochondrion. {ECO:0000250}.
FT   CHAIN        26    373       Lipoyltransferase 1, mitochondrial.
FT                                /FTId=PRO_0000017856.
FT   DOMAIN       57    243       BPL/LPL catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01067}.
FT   BINDING     107    107       Substrate; via amide nitrogen and
FT                                carbonyl oxygen. {ECO:0000250}.
FT   BINDING     151    151       Substrate. {ECO:0000250}.
FT   BINDING     161    161       Substrate. {ECO:0000250}.
FT   BINDING     179    179       Substrate. {ECO:0000250}.
FT   VARIANT      71     71       S -> F (in LIPT1D; dbSNP:rs767568897).
FT                                {ECO:0000269|PubMed:24256811}.
FT                                /FTId=VAR_073669.
FT   VARIANT      98     98       R -> G (in LIPT1D; dbSNP:rs137973334).
FT                                {ECO:0000269|PubMed:24256811}.
FT                                /FTId=VAR_073670.
FT   VARIANT     179    179       T -> A (in LIPT1D; dbSNP:rs786205156).
FT                                {ECO:0000269|PubMed:24341803}.
FT                                /FTId=VAR_073671.
SQ   SEQUENCE   373 AA;  42479 MW;  51E72E1E4F943C96 CRC64;
     MLIPFSMKNC FQLLCNCQVP AAGFKKTVKN GLILQSISND VYQNLAVEDW IHDHMNLEGK
     PILFFWQNSP SVVIGRHQNP WQECNLNLMR EEGIKLARRR SGGGTVYHDM GNINLTFFTT
     KKKYDRMENL KLIVRALNAV QPQLDVQATK RFDLLLDGQF KISGTASKIG RTTAYHHCTL
     LCSTDGTFLS SLLKSPYQGI RSNATASIPS LVKNLLEKDP TLTCEVLMNA VATEYAAYHQ
     IDNHIHLINP TDETLFPGIN SKAKELQTWE WIYGKTPKFS INTSFHVLYE QSHLEIKVFI
     DIKNGRIEIC NIEAPDHWLP LEIRDKLNSS LIGSKFCPTE TTMLTNILLR TCPQDHKLNS
     KWNILCEKIK GIM
//
